Cargando…
Making the investment case for national regulatory authorities
Well-functioning national regulatory authorities (NRAs) ensure access to safe, effective, quality-assured, and affordable medical products. However, the benefits of their work are often unseen and difficult to attribute, thereby making NRAs undervalued and under-resourced, particularly in low- and m...
Autores principales: | Twesigye, Gloria, Hafner, Tamara, Guzman, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818051/ https://www.ncbi.nlm.nih.gov/pubmed/33478590 http://dx.doi.org/10.1186/s40545-021-00299-7 |
Ejemplares similares
-
Making smart investment decisions in clinical research
por: Bansback, Nick, et al.
Publicado: (2015) -
The WHO Global Benchmarking Tool: a game changer for strengthening national regulatory capacity
por: Guzman, Javier, et al.
Publicado: (2020) -
COVID-19 vaccines pricing policy options for low-income and middle- income countries
por: Guzman, Javier, et al.
Publicado: (2021) -
Mapping global health research investments, time for new thinking - A Babel Fish for research data
por: Terry, Robert F, et al.
Publicado: (2012) -
Why We Must Invest in Early Adolescence: Early Intervention, Lasting Impact
por: Lane, Cate, et al.
Publicado: (2017)